Staying in Work With Severe Occupational Eczema: Three-Year Results From the ROQ Cohort
Doctor's Notes · Life in Motion · Research Review
By the Dr. Arsy Editorial Team · Sources checked November 2026
When occupational eczema threatens a career, a generic reminder to moisturize can feel far too small. The ROQ study examined a more intensive response: multidisciplinary rehabilitation for people with severe work-related skin disease in Germany. Its follow-up offers a useful way to discuss support, without promising that one program or product can preserve every job.
Read the work outcomes with their denominators
ROQ initially included 1,788 patients; 1,410 were available for the three-year analysis. At that follow-up, 1,166 participants, or 82.7% of those analyzed, were working. Of the working participants, 874, or 75.0%, were in the same occupational field. Measures of disease severity, quality of life and work absence improved from baseline. [1]
This prospective cohort did not randomly compare intensive rehabilitation with no rehabilitation. Loss to follow-up and changes in medical care or employment could influence outcomes. The figures should not be described as an 82.7% chance that a particular worker will keep the same job, or as evidence for a cosmetic moisturizer. [1]
| Reported group | Number | Correct comparison |
|---|---|---|
| Initially enrolled | 1,788 | Starting cohort |
| Analyzed at three years | 1,410 | Follow-up group |
| Working at three years | 1,166 | 82.7% of analyzed participants |
| Same occupational field | 874 | 75.0% of those working |
Prepare for a work-focused clinical visit
Our proposed preparation sheet has three separate headings: skin care, job tasks and support. Under skin care, note current treatment and what remains difficult. Under job tasks, name the specific activities you cannot comfortably perform. Under support, list the people who may need to coordinate, such as dermatology, occupational health and the person responsible for workplace safety.
This helps distinguish an immediate clinical need from a longer discussion about job design. A worker may want to remain in the same field but need a different exposure pattern, equipment review or a more structured return. Those possibilities require local assessment; access to the German program and its insurance system cannot be assumed elsewhere.
NIOSH's prevention framework prioritizes reducing harmful exposures. [2] For a practical meeting, ask what can be changed about the task before focusing only on what the worker must remember to do. Agree how progress will be reviewed and who will respond if symptoms worsen. These questions are our planning suggestions, not a replication of the ROQ protocol.
Eczema relief and the role of personal skin care
The phrase eczema relief covers very different expectations: less discomfort, fewer missed shifts, more comfortable hands or a response to prescribed treatment. Say which one you mean when comparing options. Dr. Arsy Moisturizer #003 offers cosmetic hydration and moisture-barrier support for dry, sensitive and eczema-prone skin. It does not provide occupational rehabilitation, and it was not the intervention tested by ROQ.
A personal after-shift moisture step can sit alongside, rather than replace, specialist management. Keep a record of the products you use so the clinical team can assess the whole routine. The choice of a cream should not delay review when work function is deteriorating.
A career decision deserves more than a percentage
The paper's population-level outcomes can start a conversation about resources; they cannot decide whether an individual should leave a profession. Financial needs, exposure options, disease severity and local services all matter. If a proposed change affects employment, involve the appropriate clinical and workplace advisers before making irreversible decisions.
A useful next appointment ends with an agreed action and a review point. That might be an exposure assessment, treatment review or discussion of a coordinated work plan. The study makes a case for taking serious occupational skin disease seriously, rather than placing the entire burden on a jar of cream.
Explore Dr. Arsy Moisturizer #003 · 4 oz
Research and guidance
Educational content; individual diagnosis and treatment belong with a qualified clinician. Researchers and cited organizations do not endorse Dr. Arsy. Campaign imagery is AI-generated from supplied brand references.